Bausch Health Companies Inc (BHC) has gained Wednesday morning, with the stock gaining 4.81% in pre-market trading to 24.6.
BHC's short-term technical score of 20 indicates that the stock has traded less bullishly over the last month than 80% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 111 out of 146 industries, Bausch Health Companies Inc ranks higher than 40% of stocks.
Bausch Health Companies Inc has risen 14.21% over the past month, closing at $20.81 on December 16. During this period of time, the stock fell as low as $19.86 and as high as $23.85. BHC has an average analyst recommendation of Strong Buy. The company has an average price target of $28.83.
Bausch Health Companies Inc has a Long-Term Technical rank of 38. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 62% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 95 by this metric, BHC ranks better than 53% of stocks.
Important Dates for Investors in BHC:
-Bausch Health Companies Inc is set to release earnings on 2/17/2021. During their last earnings release the company posted EPS of $-4.08. -We do not have a set dividend date for Bausch Health Companies Inc at this time. Click Here to get the full Stock Score Report on Bausch Health Companies Inc (BHC) Stock.